Phase 2/3 Multi-Center, Double-Blind, Controlled Trial Comparing Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir, and Combination Topical ARYS-01 Cream /Oral Valaciclovir for Treatment of Herpes Zoster in Immunocompetent Patients 18 Years of Age or Older
A multi-center, randomized, 4-arm, placebo-controlled, double-blind efficacy study of ARYS-01 (sorivudine) cream 3%.
100 Clinical Results associated with Arigen Pharmaceuticals, Inc.
0 Patents (Medical) associated with Arigen Pharmaceuticals, Inc.
01 Apr 2010·INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Corrigendum to “Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica” [Int. J. Antimicrob. Agents 31 (2010) 56–61]
Author: Vahab Ali ; Hiroyuki Yasui ; Tomoyoshi Nozaki ; Seiki Kobayashi ; Tomoyoshi Soga ; Norio Shibata ; Makoto Suematsu ; Takeshi Toru ; Gensuke Tokoro ; Masaichi Yamamoto ; Dan Sato ; Tsutomu Takeuchi
On page 60, Table 2 is incorrect; the correct version of the table is given.
100 Deals associated with Arigen Pharmaceuticals, Inc.
100 Translational Medicine associated with Arigen Pharmaceuticals, Inc.